Global Ganja Report

US Rep. Scott Perry (R-PA) on July 29 introduced a bill to legalize cannabidiol (CBD) oil on a national level, citing its effectiveness in treating seizures in children suffering from epilepsy. The "Charlotte's Web Medical Hemp Act of 2014" would remove CBD oil and "therapeutic hemp" from the federal definition of marijuana in the Controlled Substances Act. "Therapeutic hemp" is cannabis that contains no more than .3% THC and therefore produces no "high." Perry announced the bill at press conference where he was joined by the president of the national Epilepsy Foundation and advocates that included the mother of Colorado girl Charlotte Figi, whose successful treatment with  CBD  oil won national interest. Also present was Joel Stanley, one of the creators of the "Charlotte's Web" strain of marijuana used to treat Figi. Introduction of the legislation coincides with a pledge by Pennsylvania's Gov. Tom Corbett to create a state-level pilot program for families whose children require access to medical marijuana. (Jurist, July 29; PennLive, MSBC, July 28)

The American Herbal Products Association (AHPA) released its long-awaited medical marijuana manufacturing guidelines July 22, completing its compendium of industry standards which include regulatory recommendations for cannabis from seed to sale. The AHPA manufacturing guidelines come as licensed Colorado business At Home Baked sees the country's first medical marijuana product recall. A new nationwide program called Patient Focused Certification (PFC), a project of Americans for Safe Access (ASA), aims to bring greater standardization to the medical marijuana industry. The PFC program uses the recently completed AHPA guidelines in combination with standards set by American Herbal Pharmacopoeia (AHP) for the plant's identity, purity, quality and botanical properties. Together, these standards have the means to bring greater accountability to the industry and increased safety for patients.

The decrim train rolled into Philadelphia on June 19 as the City Council voted 13-3 to end marijuana arrests. As of September, if you're caught with 30 grams or less, the worst that can happen is a $25 fine. This is nothing short of a historic day for civil rights in Philadelphia,” says PhillyNORML co-chair Chris Goldstein. “We can now stop the practice of having the harshest penalties in the commonwealth of Pennsylvania for having a small amount of marijuana.” The veto-proof vote means that the ordinance, sponsored by Councilman Jim Kenney, will be enacted by September, although Mayor Michae Nutter, who opposed the ordinance, could sign it into law immediately.

Los Angeles' first-ever marijuana farmers market was ordered closed by an LA Superior Court judge July 15 after City Attorney Mike Feuer asked for a restraining order against the California Heritage Market. Over the weekend of July 4, the California Heritage Market, a marijuana collective, or dispensary as it is known to the "compassionate care" crowd, opened a warehouse for cannabis cultivators to peddle their products in an open-air atmosphere. Thousands waited for hours to wade through thick crowds looking for bargains among the 60 or so booths selling dried marijuana flowers, hash, oils, and creams. One bubbly vendor told the cameras that he "couldn't believe how high the demand was."

The media (Time, Daily Mail) are touting a new study published July 14 in the Proceedings of the National Academy of Sciences that is said to link cannabis use to anxiety and depression. The researchers studied the brains of 24 marijuana "abusers"—defined as those who smoke multiple times a day—and how they reacted to methylphenidate (more commonly known as Ritalin), a stimulant used to treat ADHD and narcolepsy. Using personality tests and brain imaging, the researchers found the cannabis users had "blunted" (no pun intended, we hope) behavioral, cardiovascular and brain responses to methylphenidate compared with control participants. The "abusers" also scored higher on negative emotional reactions. The researchers conclude that cannabis interferes with the brain's reaction to dopamine, the chemical responsible for feelings of reward and pleasure.

In another sign of the new progressive tilt in New York City politics, the New York Post reports July 8 that Brooklyn District Attorney Ken Thompson has announced that he will stop prosecuting low-level marijuana cases. Thompson's press release said his new policy is to "prevent offenders—who are disproportionately young men of color—from being saddled with a criminal record for a minor, non-violent offense." But Police Commissioner Bill Bratton said his cops will keep arresting Brooklyn's cannabis tokers anyway. "In order to be effective, our police officers must enforce the laws of the State of New York uniformly throughout all five boroughs of the City," Bratton said in his own statement. "Accordingly, the Kings County policy change will not result in any changes in the policies and procedures of the NYPD."

At the semi-annual summit of the Caribbean Community (CARICOM), held July 1-4 in Antigua, regional leaders agreed to establish a commission to review marijuana policy and assess the need for reforms. The communiqué issued at the conclusion of the meeting stated: "Heads of Government agreed to establish a Regional Commission on Marijuana to conduct a rigorous enquiry into the social, economic, health and legal issues surrounding marijuana use in the Region and to advise whether there should be a change in the current drug classification of marijuana, thereby making the drug more accessible for a range of users." Prime Minister Ralph Gonsalves of St. Vincent and the Grenadines, who pushed to get the issue on the agenda as chair of CARICOM, said: "It seems to me counterproductive to ignore the potential of an industry in respect of medical marijuana and to continue to expend police, national security, court resources on persons who consume a minuscule amount of marijuana in the privacy of their homes." (Drug Policy, July 7)

Gov. Andrew Cuomo signed a bill into law July 7 that makes New York the 23rd medical marijuana state. Advocates celebrated a deal struck last month between Cuomo and the state legislature that will protect qualified patients from arrest, prosecution and discrimination, and license up to 20 distribution facilities across the state. The new law empowers the New York State Department of Health (DOH) to license physicians to recommend marijuana to patients with cancer, HIV/AIDS, epilepsy, and a limited range of other medical conditions. However, the law only allows for products that use an extracted form of cannabis, such as oil or edibles, which are to be produced under a state-licensed manufacturing process. Advocates have voiced concerns over the law's 7% tax, and a prohibition on access to whole-plant cannabis. Advocates also raise concerns over the prohibitive cost for many patients who cannot afford to purchase what would otherwise be an inexpensive medicine to grow. The new law gives the DOH 18 months to establish regulations and will sunset in seven years. (ASA, July 7)